α4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions

Journal of Neuroimmunology

Volumn 210, Issue 1-2, 2009, Pages 92-99

  Man, Shumei ^a   Tucky, Barbara ^a   Bagheri, Nika ^b   Li, Xiaolong ^a   Kochar, Rabina ^b   Ransohoff, Richard M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

4 integrin; Adhesion; Blood brain barrier; Chemokines; Leukocyte; Multiple sclerosis; Shear stress

Indexed keywords

ALPHA4 INTEGRIN; BETA1A INTERFERON; CHEMOKINE; CYTOKINE; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; NATALIZUMAB; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN CELL; CAMERA; CELL ADHESION; CELL CULTURE; CELL INTERACTION; CLINICAL ARTICLE; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; UPREGULATION; ADOLESCENT; BIOLOGICAL MODEL; DIFFUSION CHAMBER; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; BLOOD-BRAIN BARRIER; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DIFFUSION CHAMBERS, CULTURE; ENDOTHELIAL CELLS; FEMALE; FIBRONECTINS; HUMANS; INTEGRIN ALPHA4; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERTUSSIS TOXIN; RECEPTORS, G-PROTEIN-COUPLED; YOUNG ADULT;

EID: 67349218765     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.008     Document Type: Article

References (61)

1. Bechmann I., Galea I., and Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol. 28 (2007) 5-11
2. Brunner M., Krenn C., Roth G., Moser B., Dworschak M., Jensen-Jarolim E., Spittler A., Sautner T., Bonaros N., Wolner E., Boltz-Nitulescu G., and Ankersmit H.J. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med. 30 (2004) 1468-1473
3. Burns A.R., Bowden R.A., MacDonell S.D., Walker D.C., Odebunmi T.O., Donnachie E.M., Simon S.I., Entman M.L., and Smith C.W. Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. 113 Pt 1 (2000) 45-57
4. Callahan M.K., Williams K.A., Kivisakk P., Pearce D., Stins M.F., and Ransohoff R.M. CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer. J. Neuroimmunol. 153 (2004) 150-157
5. Carman C.V., and Springer T.A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167 (2004) 377-388
6. Chaudhuri A., Yang B., Gendelman H.E., Persidsky Y., and Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111 (2008) 2062-2072
7. Collighan N., Giannoudis P.V., Kourgeraki O., Perry S.L., Guillou P.J., and Bellamy M.C. Interleukin 13 and inflammatory markers in human sepsis. Br. J. Surg. 91 (2004) 762-768
8. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62 (2003) 127-136
9. Deem T.L., bdala-Valencia H., and Cook-Mills J.M. VCAM-1 activation of endothelial cell protein tyrosine phosphatase 1. B. J. Immunol. 178 (2007) 3865-3873
10. Doring A., Wild M., Vestweber D., Deutsch U., and Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 179 (2007) 8470-8479
11. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., and Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60 (1990) 577-584
12. Elices M.J., Tsai V., Strahl D., Goel A.S., Tollefson V., Arrhenius T., Wayner E.A., Gaeta F.C., Fikes J.D., and Firestein G.S. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Invest. 93 (1994) 405-416
13. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005) 485-495
14. Engelhardt B., and Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur. J. Immunol. 34 (2004) 2955-2963
15. Ganji S.H., Qin S., Zhang L., Kamanna V.S., and Kashyap M.L. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 202 (2009) 68-75
16. Guan J.L., and Hynes R.O. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell 60 (1990) 53-61
17. Gutman A., and Kornblihtt A.R. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7179-7182
18. Hallgren J., Jones T.G., Abonia J.P., Xing W., Humbles A., Austen K.F., and Gurish M.F. Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 20478-20483
19. Hartmann T.N., Grabovsky V., Pasvolsky R., Shulman Z., Buss E.C., Spiegel A., Nagler A., Lapidot T., Thelen M., and Alon R. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 84 (2008) 1130-1140
20. Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8 (1990) 365-400
21. Hudetz A.G., Fehér G., and Kampine J.P. Heterogeneous autoregulation of cerebrocortical capillary flow: evidence for functional thoroughfare channels?. Microvasc. Res. 51 (1996) 131-136
22. Kabir K., Keller H., Grass G., Minor T., Stueber F., Schroeder S., Putensen C., Paul C., Burger C., Rangger C., Neville L.F., and Mathiak G. Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int. J. Mol. Med. 12 (2003) 565-570
23. Kallmann B.A., Hummel V., Lindenlaub T., Ruprecht K., Toyka K.V., and Rieckmann P. Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1. Brain 123 Pt 4 (2000) 687-697
24. Kent S.J., Karlik S.J., Cannon C., Hines D.K., Yednock T.A., Fritz L.C., and Horner H.C. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J. Neuroimmunol. 58 (1995) 1-10
25. Khatri B.O., Man S., Giovannoni G., Koo A.P., Lee J.C., Tucky B., Lynn F., Jurgensen S., Woodworth J., Goelz S., Duda P.W., Panzara M.A., Ransohoff R.M., and Fox R.J. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72 (2009) 402-409
26. Kivisakk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., Wu L., Baekkevold E.S., Lassmann H., Staugaitis S.M., Campbell J.J., and Ransohoff R.M. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8389-8394
27. Kraus J., Ling A.K., Hamm S., Voigt K., Oschmann P., and Engelhardt B. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 56 (2004) 192-205
28. Krumbholz M., Meinl I., Kümpfel T., Hohlfeld R., and Meinl E. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71 (2008) 1350-1354
29. Lossinsky A.S., and Shivers R.R. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol. Histopathol. 19 (2004) 535-564
30. Luscinskas F.W., Ma S., Nusrat A., Parkos C.A., and Shaw S.K. The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol. Rev. 186 (2002) 57-67
31. Luster A.D., Alon R., and Von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6 (2005) 1182-1190
32. Mahad D., Callahan M.K., Williams K.A., Ubogu E.E., Kivisakk P., Tucky B., Kidd G., Kingsbury G.A., Chang A., Fox R.J., Mack M., Sniderman M.B., Ravid R., Staugaitis S.M., Stins M.F., and Ransohoff R.M. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 129 Pt. 1 (2006) 212-223
33. Man S., Ubogu E.E., and Ransohoff R.M. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 17 (2007) 243-250
34. Man S., Ubogu E.E., Williams K.A., Tucky B., Callahan M.K., and Ransohoff R.M. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin. Dev. Immunol. 2008 (2008) 384982
35. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., Simmons D., and Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142 (1998) 117-127
36. McCandless E.E., Piccio L., Woerner B.M., Schmidt R.E., Rubin J.B., Cross A.H., and Klein R.S. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172 (2008) 799-808
37. Miyake Y., Mochizuki M., Ito C., Itoigawa M., and Osawa T. Antioxidative pyranonigrins in rice mold starters and their suppressive effect on the expression of blood adhesion molecules. Biosci. Biotechnol. Biochem. 72 (2008) 1580-1585
38. Navarro P., Ruco L., and Dejana E. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J. Cell. Biol. 140 (1998) 1475-1484
39. Needham L.A., Van D.S., Pigott R., Edwards R.M., Shepherd M., Hemingway I., Jack L., and Clements J.M. Activation dependent and independent VLA-4 binding sites on vascular cell adhesion molecule-1. Cell Adhes. Commun. 2 (1994) 87-99
40. Peterson J.W., Bo L., Mork S., Chang A., Ransohoff R.M., and Trapp B.D. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 61 (2002) 539-546
41. Polman C.H., O'Connor P.W., Havrdova E., Hutchinson M., Kappos L., Miller D.H., Phillips J.T., Lublin F.D., Giovannoni G., Wajgt A., Toal M., Lynn F., Panzara M.A., and Sandrock A.W. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354 (2006) 899-910
42. Ransohoff R.M. Natalizumab for multiple sclerosis. N. Engl. J. Med. 356 (2007) 2622-2629
43. Ransohoff R.M., Man S., and Ubogu E.E. "Doing the locomotion" with the multistep paradigm. Blood 109 (2007) 1342-1343
44. Rice G.P., Hartung H.P., and Calabresi P.A. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64 (2005) 1336-1342
45. Rudick R.A., Stuart W.H., Calabresi P.A., Confavreux C., Galetta S.L., Radue E.W., Lublin F.D., Weinstock-Guttman B., Wynn D.R., Lynn F., Panzara M.A., and Sandrock A.W. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N. Engl. J. Med. 354 (2006) 911-923
46. Schreiber T.H., Shinder V., Cain D.W., Alon R., and Sackstein R. Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. Blood 109 (2007) 1381-1386
47. Sellebjerg F., Ross C., Koch-Henriksen N., Sørensen P.S., Frederiksen J.L., Bendtzen K., and Sørensen T.L. CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis. Mult. Scler. 11 (2005) 641-645
48. Shulman Z., Pasvolsky R., Woolf E., Grabovsky V., Feigelson S.W., Erez N., Fukui Y., and Alon R. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood 108 (2006) 2150-2158
49. Spertini F., Wang A.V., Chatila T., and Geha R.S. Engagement of the common leukocyte antigen CD45 induces homotypic adhesion of activated human T cells. J. Immunol. 153 (1994) 1593-1602
50. Stins M.F., Gilles F., and Kim K.S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76 (1997) 81-90
51. Ting K.M., Rothaupt D., McCormick T.S., Hammerberg C., Chen G., Gilliam A.C., Stevens S., Culp L., and Cooper K.D. Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin. J. Invest. Dermatol. 114 (2000) 706-711
52. Ubogu E.E., Callahan M.K., Tucky B.H., and Ransohoff R.M. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation. J. Neuroimmunol. 179 (2006) 132-144
53. Van der Laan L.J., Van der G.A., Wauben M.H., Ruuls S.R., Dopp E.A., De Groot C.J., Kuijpers T.W., Elices M.J., and Dijkstra C.D. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. J. Neurosci. Res. 67 (2002) 191-199
54. Van H.J., Bo L., Vos C.M., Virtanen I., and De Vries H.E. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J. Neuropathol. Exp. Neurol. 64 (2005) 722-729
55. Von Andrian U.H., and Engelhardt B. Alpha4 integrins as therapeutic targets in autoimmune disease. N. Engl. J. Med. 348 (2003) 68-72
56. Vorbrodt A.W., and Dobrogowska D.H. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem. Cytobiol. 42 (2004) 67-75
57. Wagner C., Pioch M., Meyer C., Iking-Konert C., Andrassy K., and Hansch G.M. Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin. J. Mol. Med. 78 (2000) 337-345
58. Wang H., Sun J., and Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J. Virol. 82 (2008) 7591-7600
59. Watanabe E., Hirasawa H., Oda S., Matsuda K., Hatano M., and Tokuhisa T. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit. Care Med. 33 (2005) 89-97
60. Wong D., Prameya R., and Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58 (1999) 138-152
61. Woolf E., Grigorova I., Sagiv A., Grabovsky V., Feigelson S.W., Shulman Z., Hartmann T., Sixt M., Cyster J.G., and Alon R. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat. Immunol. 8 (2007) 1076-1085